CSI Market
Sign In | Register

Dicerna Pharmaceuticals Inc (DRNA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DRNA Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Dicerna Pharmaceuticals Inc manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2021)
(Jun 30 2021) (Mar 31 2021) (Dec 31 2020) (Sep 30 2020)
Assets
Cash & cash equivalent165.76
Restricted Cash and Cash Equivalents, Current0.00
Held-to-maturity Securities, Current MA30.00
Cash & Short-term Investments165.00
Accounts receivable6.23
Other Current Assets399.75
Prepaid Expense And Other Assets Current17.27
Total Current Assets589.00
Equipment/Property/Plant Net0.00
Long-term investments5.62
Other Assets, Noncurrent106.00
Operating Lease Right Of Use Asset72.43
Total Assets772.06
Liabilities
Accounts Payable, Current AC8.32
Accrued Liabilities And Other Liabilities34.13
Other Liabilities, Current196.85
Total Current Liabilities239.30
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE4.00
Other liabilities, Noncurrent421.10
Contract With Customer Liability Current190.13
Contract With Customer Liability Noncurrent180.79
Total Liabilities664.40
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock833.57
Retained Earnings / Accumulated Deficit-725.92
Other Equity0.00
Common Stockholder's Equity107.66
Total Stockholder's Equity107.66
Liabilities & Stockholder's Equity772.06
4 historic quarters locked

Sign in to unlock the full Dicerna Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About DRNA Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.